Well they could purchase the AS and sell back into the market diluting after a ticker change and basically finance this whole buy out. 130 mil AS x couple bucks per share = BioAmber purchase basically free with nols intact. Or am I wrong? So they could purchase all assets including AS for say 250 mil and sell off the AS after the deal closes and boom free deal so to speak. All legal as far as I know. IMO of course and I don’t feel this is a far fetched idea.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.